Overview
- Description
The company is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space, with first indication in pancreatic cancer.
- Website
- Country
- Spain
- Sector
- Health Biotechnology
Engage with Ability Pharmaceuticals*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.
